2022
DOI: 10.1039/d1cp05736g
|View full text |Cite
|
Sign up to set email alerts
|

Molecular insights into the allosteric coupling mechanism between an agonist and two different transducers for μ-opioid receptors

Abstract: G protein-coupled receptors (GPCRs) as the most important class of pharmacological targets regulate G-protein and β-arrestin-mediated signaling through allosteric interplay, which are responsible for different biochemical and physiological actions like...

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
6
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3
1

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(8 citation statements)
references
References 87 publications
(110 reference statements)
2
6
0
Order By: Relevance
“…101,119 Furthermore, the interaction of M3.46 with R3.50 was found to be associated with the G-protein coupling for the class A GPCRs. 80 Interestingly, the residues constituting the shortest pathway in the DAMGO-μOR monomer system are highly consistent with that revealed by a recent aMD study on the DAMGO-μOR-G-protein ternary complex system 69 despite the fact that DAMGO is a balanced μOR agonist. However, it is noted that the initial structure of the MD simulation on the DAMGO-μOR monomer is based on the crystal structure of the DAMGO-μOR-G-protein crystal structure (PDB ID: 6DDE) that represents the G-protein biased conformation, only removing the G-protein.…”
Section: Impact Of the Heterodimerization On The Structural Communica...supporting
confidence: 81%
See 4 more Smart Citations
“…101,119 Furthermore, the interaction of M3.46 with R3.50 was found to be associated with the G-protein coupling for the class A GPCRs. 80 Interestingly, the residues constituting the shortest pathway in the DAMGO-μOR monomer system are highly consistent with that revealed by a recent aMD study on the DAMGO-μOR-G-protein ternary complex system 69 despite the fact that DAMGO is a balanced μOR agonist. However, it is noted that the initial structure of the MD simulation on the DAMGO-μOR monomer is based on the crystal structure of the DAMGO-μOR-G-protein crystal structure (PDB ID: 6DDE) that represents the G-protein biased conformation, only removing the G-protein.…”
Section: Impact Of the Heterodimerization On The Structural Communica...supporting
confidence: 81%
“…Although its role in the GPCR signaling was rarely reported, mutations of D 1 R showed that the residue at position 8.56 significantly affects the selectivity of the receptor to transducers . Recently, R34.57 (in ICL2) has been reported by MD simulations to be associated with the coupling of μOR with β-arrestin. , Our result further reveals that these key residues found in the GPCR monomer also involve in the signaling of the μOR/δOR heterodimer. In addition, it is worthy to be noted that some residues involved in TM1, TM2, and H8, which present relatively high frequencies in the allosteric network, are not hot spot residues of the dimer interface, suggesting that different residues on the interface conduct distinct functions.…”
Section: Resultssupporting
confidence: 61%
See 3 more Smart Citations